RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Allergan Inc.

A collection of news and information related to Allergan Inc. published by this site and its partners.

Top Allergan Inc. Articles

Displaying items 78-88
  • FDA's 1-800-GET-THIN warning follows L.A. County official's complaint

     
    The Food and Drug Administration has ordered 1-800-GET-THIN, the company behind the advertising campaign for Lap-Band weight-loss surgery, to take better steps to warn consumers about risks of such procedures. The move comes one year after Los Angeles...
  • FDA accuses 1-800-GET-THIN centers of deceptive advertising

     
    Weight loss surgical centers affiliated with 1-800-GET-THIN have been accused by the U.S. Food and Drug Administration for misleading consumers about the risks of the device used to treat obesity....
  • 1-800-GET-THIN warns of Lap-Band death risk

     
    The 1-800-GET-THIN marketing company has placed a prominent warning on its website about the risks of Lap-Band surgery. Earlier this month, the Food and Drug Administration said it had warned 1-800-GET-THIN that its advertisements for Lap-Band weight-loss...
  • Is New Eyelash Drug for You?

    Is New Eyelash Drug for You?
    If you don't like to wear mascara becauser it makes your eyelashes stick together and leaves black smudges under your eyes, and false eyelashes hold no appeal for you, perhaps you should use the new drug Latisse, approved by the Food and Drug...
  • It's a Love/Hate Thing

    It's a Love/Hate Thing
    Taking a prescription drug for a positive cosmetic side effect - at the risk of experiencing other unwanted side effects - may seem risky. But it's a risk many American women have shown themselves happy to take. Latisse, originally a glaucoma drug...
  • Lash Enhancers Now a Growth Business

    Lash Enhancers Now a Growth Business
    Brooke Shields beams into the camera, her sea-green eyes framed by long, dark lashes, doing the cha-cha and helping a friend blow out birthday candles. In the ubiquitous commercials for the lash-growing product Latisse, the actress and model is saying...
  • Is Latisse Worth the Risks?

    Is Latisse Worth the Risks?
    For about $100 a month, you could have the long, thick, dark eyelashes that you've always wanted. But Latisse, a drug that can treat the new medical condition "inadequate eyelashes," also has a few unpleasant side effects. It may grow excessive hair in...
  •  

     
     
     
  • Get botox, land that job!

    Get botox, land that job!
    Every so often, I open an E-mail that makes me cringe. A press release titled "How Botox can help you get a new job" brought out those frown lines. It detailed a study published in the June issue of the journal Dermatologic Surgery in which 300 volunteers...
  • Latisse lash lengthener has its fans and detractors

    Latisse lash lengthener has its fans and detractors
    Taking a prescription drug for a cosmetic side effect -- at the risk of other side effects -- may seem risky. But it's a risk that many Americans, mostly women, have shown themselves happy to take. Latisse, originally a glaucoma drug marketed under the...
  • It's A Love/hate Thing Many Women Swear It Works, But The Drug, Developed To Treat Glaucoma, Can Cause Unpleasant Side Effects

    Taking a prescription drug for a positive cosmetic side effect -- at the risk of experiencing other unwanted side effects -- may seem risky. But it's a risk many American women have shown themselves happy to take. Latisse, originally a glaucoma drug...